Clinical Trial Update: Qvanteq Bioactive Coronary Stent System First in Man (FIM) Clinical Investigation [NA]

View source ↗

Summary

The document reports the completion status of the first-in-man investigation of the Qvanteq Bioactive Coronary Stent System for Coronary Artery Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Qvanteq Bioactive Coronary Stent System

Snippet

Sponsor: Qvanteq AG | Conditions: Coronary Artery Disease | NA | Status: COMPLETED